Haixin Yu

8PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCell development, proliferation and deathCancer diagnosisMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2024
ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation.

Qun Zhang, Zhouyuan Du, Wei Zhou

|Mar 31, 2023
TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks.

Jian Ma, Yingke Zhou, Penglin Pan

|Sep 14, 2022
HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer.

Penglin Pan, Gengdu Qin, Bo Wang

|Nov 17, 2021
Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma.

Xin Jin, Bin Zhang, Hao Zhang

|Oct 15, 2021
The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancer.

Lu Yi, Haohui Wang, Wei Li

|Jun 20, 2020
Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.

Haixin Yu, Janhavi R Raut, Ben Schöttker

Pageof 2

Frequent Collaborators

1 joint publications

Zhong Guan

1 joint publications

Hermann Brenner

1 joint publications

Xin Jin

1 joint publications

Hao Zhang